drugset / Trial / NCT06425861
A First in Human Trial Evaluating THB335 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a double blind, randomized, placebo-controlled, Phase 1 study in three parts: single ascending doses and food effect (Part 1), multiple ascending doses (Part 2) and Relative Bioavailability of Two Formulations (Part 3).
Timeline
- Start
- 2024-05-02
- Primary completion
- 2024-12-18
- Completion
- 2024-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | THB335 | Unknown | — | Oral |
Indications
No indication recorded.